“Miso Information Technology (CEO Dong-wook Ahn), a multi-modal data platform specialist, announced on the 24th that it has signed a customized healthcare business partnership with Once Global (CEO Kyung-ha Park), a pharmaceutical data solution specialist, to expand the market by standardizing pharmaceutical information, improving medication management solutions, and providing medical MyData business using a multi-modal data platform and artificial intelligence technology.”
Smile Information Technology is rapidly supporting the digital transformation of the medical and non-medical fields by utilizing 'SmartTA M-LLM', a knowledge asset solution that classifies knowledge information stored in various document formats such as hospital medical records, health check-up questionnaires, results sheets, and pharmacy prescriptions and uses advanced linguistic rules (AGI) to classify multiple attributes. In addition, it is preparing a digital healthcare business in preparation for the aging society by expanding the business to include the construction of a medical big data platform based on medical data integration and clinical research solutions with university hospitals and general hospitals across the country such as Yonsei Medical Center, Konkuk University Hospital, and Chonnam National University Hospital as its customers and the recent personal health record (PHR) business that records and manages personal health information.
Through this business partnership with Once Global, we will standardize medicine and drug information, enhance data quality, and advance medication management solutions, which will be provided to medical institutions, insurance companies, and pharmaceutical companies. In particular, as domestic and international pharmaceutical companies are increasingly converting general medicines into health functional foods (health food), concerns about consumer health are increasing due to blind use, etc., so we will provide information on interactions between medicines (drugs) and health functional foods (health food), contraindications, cautions, and overlapping drugs. We also plan to provide medication management solutions for cancer patients and personalized content based on medical MyData to improve treatment satisfaction.
The current Pharmaceutical Affairs Act defines medication guidance as “an act of providing information such as the name, usage, dosage, efficacy, storage method, side effects, or interactions of a prepared drug.” Elderly patients often take multiple medications at the same time due to chronic diseases, and side effects suddenly occur even with medications they have been taking regularly. Therefore, caution is required when using medications as the possibility of side effects increases when mixing medications. To address this, the two companies plan to raise awareness of drug treatment principles and provide essential services to service providers such as doctors, pharmacists, and nurses who care for elderly patients.
Mr. Ahn Dong-wook, CEO of Smile Information Technology, said, “Every year, the purchase of various medicines through domestic and overseas direct purchases is increasing, and anxiety about side effects such as blind use is growing. We will work with Once Global to standardize high-quality medicine data and advance customized medication management solutions to become a safe and reliable pharmaceutical data enabler.”
Meanwhile, good news is opening up for the medical and non-medical businesses of micro information technology. Under the leadership of the Personal Information Protection Commission, MyData (the right to request personal information transmission) in the medical and communication fields has been fully implemented. In the early stages of the system, it will be implemented first in the medical field, which has a large ripple effect. It is expected that the MyData business will grow rapidly with efficient medical data review (DRB) solutions, such as the integrated solution for clinical research support for upper-level general hospitals, multi-modal data platforms, health data distribution platforms for medical device and service development, data pseudonymization and utilization, external transmission, and dynamic consent, which are the main business areas of micro information technology. In addition, since the implementation of MyData is expected in all fields, including distribution, transportation, education, employment, real estate, welfare, and leisure, including the expansion to the energy field in June next year, good results are also expected for the growth of non-medical fields of micro information technology, such as manufacturing data analysis and AI autonomous manufacturing process solutions.
- See more related articles
You must be logged in to post a comment.